With the injectable antiretroviral drug lenacapavir found to be “safe and 100% effective as long-acting HIV pre-exposure prophylaxis (PrEP) among cisgender women in a...
A man in Toronto, Canada was infected with HIV despite regularly taking pre-exposure prophylaxis (PrEP)/Truvada. The man, who reported having sex with men, began...